46 related articles for article (PubMed ID: 10438350)
1. Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets.
Gonzalez VD; Björkström NK; Malmberg KJ; Moll M; Kuylenstierna C; Michaëlsson J; Ljunggren HG; Sandberg JK
J Immunol Methods; 2008 Jan; 330(1-2):64-74. PubMed ID: 18083186
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.
Herasimtschuk AA; Westrop SJ; Moyle GJ; Downey JS; Imami N
J Immune Based Ther Vaccines; 2008 Oct; 6():7. PubMed ID: 18976455
[TBL] [Abstract][Full Text] [Related]
3. A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy.
Hardy GA; Imami N; Nelson MR; Sullivan AK; Moss R; Aasa-Chapman MM; Gazzard B; Gotch FM
J Immune Based Ther Vaccines; 2007 Apr; 5():6. PubMed ID: 17428345
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
Akahata W; Yang ZY; Nabel GJ
J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection.
Gamberg J; Barrett L; Bowmer I; Howley C; Grant M
J Clin Immunol; 2004 Mar; 24(2):115-24. PubMed ID: 15024178
[TBL] [Abstract][Full Text] [Related]
6. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
Imami N; Pires A; Hardy G; Wilson J; Gazzard B; Gotch F
J Virol; 2002 Sep; 76(18):9011-23. PubMed ID: 12186885
[TBL] [Abstract][Full Text] [Related]
7. Prospects for immune reconstitution in HIV-1 infection.
Imami N; Gotch F
Clin Exp Immunol; 2002 Mar; 127(3):402-11. PubMed ID: 11966755
[No Abstract] [Full Text] [Related]
8. Vaccine development against HIV-1: current perspectives and future directions.
Edgeworth RL; San JH; Rosenzweig JA; Nguyen NL; Boyer JD; Ugen KE
Immunol Res; 2002; 25(1):53-74. PubMed ID: 11868934
[TBL] [Abstract][Full Text] [Related]
9. T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).
Moss RB; Giermakowska W; Wallace MR; Savary J; Jensen F; Carlo DJ
Clin Diagn Lab Immunol; 2000 Sep; 7(5):724-7. PubMed ID: 10973444
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.
Garzino-Demo A; Moss RB; Margolick JB; Cleghorn F; Sill A; Blattner WA; Cocchi F; Carlo DJ; DeVico AL; Gallo RC
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11986-91. PubMed ID: 10518563
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.
Trauger RJ; Daigle AE; Giermakowska W; Moss RB; Jensen F; Carlo DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S74-82. PubMed ID: 7552517
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
13. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjects.
Moss RB; Li L; Giermakowska WK; Lanza P; Turner JL; Wallace MR; Jensen FC; Richieri SP; Daigle AE; Theofan G; Carlo DJ
J Hum Virol; 1998; 1(2):77-81. PubMed ID: 10195235
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
